Gevo revenue misses expectations, analysts cut forecasts

ENGLEWOOD – Gevo (NASDAQ:), Inc., a renewable chemicals and advanced biofuels company, reported quarterly revenues of $4.5 million, which fell below analyst expectations. The company also posted a larger-than-anticipated loss of $0.07 per share. Following these results, analysts have revised their forecasts for the company’s performance in 2024.

The new revenue forecast for 2024 stands at $20.5 million, indicating a 53% improvement from the previous year. However, this revision also comes with an expectation of a widened loss of $0.26 per share, compared to the earlier estimate of an $0.11 loss per share. Despite these adjustments, the consensus price target for Gevo’s stock remains unchanged at $4.52.

Analysts are divided on Gevo’s future prospects, with price targets ranging significantly from a high of $14.00 to a low of $1.50 per share. This disparity underscores the differing opinions on the company’s potential to leverage its position in the renewable energy sector.

Gevo is expected to see a significant acceleration in its growth rate, with analysts predicting an annual increase in revenues of 41% leading up to 2024. This expected growth is in stark contrast to the company’s historical performance, which saw an annual decline in revenues of 50% over the past five years. In comparison to other companies within the same industry, which are projected to experience a slight annual revenue decline of 0.2%, Gevo is positioned for faster growth among its peers.

Despite the anticipated increase in loss per share for the next year, the steady consensus price target suggests that analysts believe Gevo’s long-term earnings trajectory holds promise and that its intrinsic business value remains stable. Analysts appear to be focusing more on Gevo’s potential for long-term earnings rather than its short-term financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.